China Diabetic Neuropathy Treatment Market Size & Outlook
China diabetic neuropathy treatment market, 2018-2030 (US$M)
Related Markets
China diabetic neuropathy treatment market highlights
- The China diabetic neuropathy treatment market generated a revenue of USD 215.4 million in 2023 and is expected to reach USD 474.9 million by 2030.
- The China market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, peripheral neuropathy was the largest revenue generating disorder type in 2023.
- Autonomic Neuropathy is the most lucrative disorder type segment registering the fastest growth during the forecast period.
Diabetic neuropathy treatment market data book summary
| Market revenue in 2023 | USD 215.4 million |
| Market revenue in 2030 | USD 474.9 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Peripheral neuropathy |
| Fastest growing segment | Autonomic Neuropathy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy |
| Key market players worldwide | Abbott Laboratories, Eli Lilly and Co, Pfizer Inc, Janssen Pharmaceuticals, Lupin, Astellas Pharma Inc, Glenmark Pharmaceuticals, Boehringer Ingelheim, Novartis AG ADR |
Other key industry trends
- In terms of revenue, China accounted for 5.0% of the global diabetic neuropathy treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China diabetic neuropathy treatment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 474.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetic Neuropathy Treatment Market Scope
Diabetic Neuropathy Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China diabetic neuropathy treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic neuropathy treatment market will help companies and investors design strategic landscapes.
Peripheral neuropathy was the largest segment with a revenue share of 63.09% in 2023. Horizon Databook has segmented the China diabetic neuropathy treatment market based on peripheral neuropathy, autonomic neuropathy, proximal neuropathy, focal neuropathy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to China diabetic neuropathy treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China diabetic neuropathy treatment market databook
-
Our clientele includes a mix of diabetic neuropathy treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China diabetic neuropathy treatment market, including forecasts for subscribers. This country databook contains high-level insights into China diabetic neuropathy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China diabetic neuropathy treatment market report size, by disorder type, 2018-2030 (US$M)
China Diabetic Neuropathy Treatment Market Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
